Arthrosurface Incorporated
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$2.1Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
1,878clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Ovomotion $324K associated (2023-2025)
- Revomotion $282K associated (2023-2025)
- Wavekahuna $252K associated (2023-2025)
- Glenojet $248K associated (2023-2025)
- Unicap $247K associated (2023-2025)
- Speedspiral Cmc System $107K associated (2023-2025)
- Wristmotion Wrist Hemiarthroplasty System $97K associated (2023-2025)
- Hemicap $4,121 associated (2023-2025)
- Toe Motiontm $4,063 associated (2023-2025)
- Hemicapovo $2,495 associated (2023-2025)
- Toemate $1,647 associated (2023-2025)
- Arthrosurface Bone Screw $1,188 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Anthony Miniaci | Cleveland, OH | Orthopaedic Surgery | $883,628.21 |
| Arnold-Peter Weiss | Providence, RI | Hand Surgery | $122,598.14 |
| In Yi | Lonetree, CO | Hand Surgery | $118,175.53 |
| Randall Culp | Plains, PA | Hand Surgery | $117,662.52 |
| Joseph Sherrill | Birmingham, AL | Orthopaedic Surgery | $115,855.78 |
| Steven Brotzman | Austin, TX | $114,671.34 | |
| Gregory Nicholson | Chicago, IL | Sports Medicine (Orthopaedic Surgery) | $69,682.59 |
| Carl Hasselman | Pittsburgh, PA | $60,717.74 | |
| Ronald Dumigan | Oklahoma City, OK | Orthopaedic Surgery | $60,473.74 |
| David Ruch | Durham, NC | Orthopaedic Surgery | $32,721.07 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.